Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion

기사 요약

Alnylam stock rises after a $2 billion AI-driven RNAi drug discovery collaboration with Inceptive as analysts maintain bullish price targets.